| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/02/2006 | US20060024290 prophylactic and/or therapeutic agent for the modification of fertility and behaviour patterns of animals, the achievement of livestock production gains such as increasing growth, decreasing feed conversion ratios or the control of unwanted organoleptic characteristics |
| 02/02/2006 | US20060024283 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 02/02/2006 | US20060024275 Methods for use of MPL ligands with primitive human stem cells |
| 02/02/2006 | US20060024272 C-terminally truncated interferon |
| 02/02/2006 | US20060024269 Treating cancer, inhibiting cancer progression and reducing side effects by administering an interleukin having a specific sequence and optionally polyethylene glycol (monomethoxy-polyethylene glycol propionaldehyde) that may be covalently linked amino-terminally to the polypeptide |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | DE19856463B4 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors |
| 02/02/2006 | CA2616277A1 Urine markers for detection of bladder cancer |
| 02/02/2006 | CA2579753A1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 02/02/2006 | CA2579674A1 Method for preventing dehiscence and altering plant lignification |
| 02/02/2006 | CA2575462A1 Mutations in erb2 associated with cancerous phenotypes |
| 02/02/2006 | CA2575441A1 Linkers |
| 02/02/2006 | CA2575356A1 Use of llt1 and/or cd161 for modulating the activity of cells of the immune system |
| 02/02/2006 | CA2575218A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 02/02/2006 | CA2574777A1 Actrii receptor polypeptides, methods and compositions |
| 02/02/2006 | CA2574654A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/02/2006 | CA2574564A1 Use of il-28 and il-29 to treat cancer and autoimmune disorders |
| 02/02/2006 | CA2574375A1 Polypeptides for oligomeric assembly of antigens |
| 02/02/2006 | CA2572239A1 B7-h5, a costimulatory polypeptide |
| 02/02/2006 | CA2571426A1 Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (trail) |
| 02/02/2006 | CA2571261A1 Safer attenuated virus vaccines with missing or diminished latency of infection |
| 02/01/2006 | EP1621635A2 Self-assembling recombinant HP16 papillomavirus capsid proteins |
| 02/01/2006 | EP1621634A1 Multiple gene transcription activity determining system |
| 02/01/2006 | EP1621633A2 Glycoproteins produced in plants with suppressed expression of beta 1, 2-xylosyltransferase |
| 02/01/2006 | EP1621630A1 Method for preventing dehiscence and altering plant lignification |
| 02/01/2006 | EP1621623A2 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitis |
| 02/01/2006 | EP1621621A1 Human 7tm protein receptors and polynucleotides encoding the same |
| 02/01/2006 | EP1621620A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2006 | EP1621619A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2006 | EP1621615A1 Method of purifying modified acarian main allergen |
| 02/01/2006 | EP1621612A1 Complete empty viral particles of infectious bursal disease virus (ibdv), production method thereof and applications of same |
| 02/01/2006 | EP1621555A1 Immunogen, composition for immunological use, and method of producing antibody using the same |
| 02/01/2006 | EP1621554A1 Immunoglobulins devoid of light chains |
| 02/01/2006 | EP1621552A1 Human trace amine associated receptors (hTAAR) |
| 02/01/2006 | EP1621551A1 Use of LLT1 and/or CD161 for modulating the activity of cells of the immune system |
| 02/01/2006 | EP1621550A1 Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) |
| 02/01/2006 | EP1621549A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments |
| 02/01/2006 | EP1621548A2 Polypeptides, CDNAs encoding the same and utilization thereof |
| 02/01/2006 | EP1621547A1 C of malarial pre-erythrocytic stage polypeptide molecules and lipids |
| 02/01/2006 | EP1621208A1 DNA vaccination for treatment of autoimmune disease |
| 02/01/2006 | EP1621206A1 Chimeric cytokines and uses thereof |
| 02/01/2006 | EP1621203A1 RNAIII-inhibiting peptides for treating HIV infection |
| 02/01/2006 | EP1620555A2 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 02/01/2006 | EP1620554A2 Recombinant fel d 1 allergen |
| 02/01/2006 | EP1620552A2 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 02/01/2006 | EP1620539A2 Transgenic plants with increased glycine-betaine |
| 02/01/2006 | EP1620468A1 Fusion polypeptide suitable as a cytotoxin |
| 02/01/2006 | EP1620466A2 Secreted protein family |
| 02/01/2006 | EP1620465A2 Insulin analogs having protracted time action |
| 02/01/2006 | EP1620464A1 Combined use of keratinocyte growth factor agonists and gastrin compounds |
| 02/01/2006 | EP1620463A2 Compositions and methods comprising a ligand of chemerin receptor |
| 02/01/2006 | EP1620462A2 Nogo- b, a regulator of endothelial cell function and vessel remodeling |
| 02/01/2006 | EP1620461A2 Group 1 mite polypeptide variants |
| 02/01/2006 | EP1620460A2 Streptococcus agalactiae antigens i + ii |
| 02/01/2006 | EP1620459A2 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 02/01/2006 | EP1620453A2 Modulation of glucagon receptor expression |
| 02/01/2006 | EP1620449A2 Differentially expressed nucleic acids that correlate with ksp expression |
| 02/01/2006 | EP1620129A2 Cyanovirin variant-polymer conjugates |
| 02/01/2006 | EP1620120A2 Long acting biologically active conjugates |
| 02/01/2006 | EP1620112A2 Desmoglein 4 is a novel gene involved in hair growth |
| 02/01/2006 | EP1620061A2 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/01/2006 | EP1620056A2 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 02/01/2006 | EP1619992A2 Expressed genes that define the osteoclast phenotype |
| 02/01/2006 | EP1619958A1 Peptides having an ace inhibiting effect |
| 02/01/2006 | EP1619957A1 Hydrolysed casein product comprising tripeptides ipp and/ or vpp |
| 02/01/2006 | EP1619951A2 Methods and compositions for treating disorders |
| 02/01/2006 | EP1571898A4 Generation of plants with altered oil content |
| 02/01/2006 | EP1485406A4 Highly homogeneous molecular markers for electrophoresis |
| 02/01/2006 | EP1465907A4 Modular peptide-based reagent |
| 02/01/2006 | EP1427747A4 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 02/01/2006 | EP1402025B1 Chimaeric phages |
| 02/01/2006 | EP1223953B1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 02/01/2006 | EP1200479B1 Multiple cytokine-antibody complexes |
| 02/01/2006 | EP1196566B1 Expression vectors and methods |
| 02/01/2006 | EP1179592B1 Proteins nectin-3 |
| 02/01/2006 | EP1115849B1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 02/01/2006 | EP1101819B1 GENE Any-RF, DORMANCY REGULATORY SUBSTANCE, PROCESS FOR PRODUCING THE SAME AND CELL REGULATOR FOR VITAL CELLS |
| 02/01/2006 | EP1100960A4 Bivalent binding molecules of 7 transmembrane g protein-coupled receptors |
| 02/01/2006 | EP1047448B1 Dna vaccines against tick-borne flaviviruses |
| 02/01/2006 | EP0969854B1 Inhibition of signal transduction by the binding of non-phosphorylated compositions |
| 02/01/2006 | EP0934418B1 Microbial preparation of substances from aromatic metabolism/i |
| 02/01/2006 | EP0922056B1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 02/01/2006 | EP0907736B1 Cc-type chemokines |
| 02/01/2006 | EP0906119B1 Stimulation of host defense mechanisms against cancer |
| 02/01/2006 | EP0835313B1 Omp26 antigen from haemophilus influenzae |
| 02/01/2006 | EP0264434B2 Detection of a unique chlamydia strain associated with acute respiratory disease |
| 02/01/2006 | CN1729295A Preparation of antifreeze protein |
| 02/01/2006 | CN1729292A DNA sequences from tcd genomic region of photorhabdus luminescens |
| 02/01/2006 | CN1729290A Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 02/01/2006 | CN1729202A Targeting single epitopes |
| 02/01/2006 | CN1729201A Isolated fluorescent protein from clytia gregaria CGFP and use thereof |
| 02/01/2006 | CN1729018A G-CSF conjugates |
| 02/01/2006 | CN1729015A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 02/01/2006 | CN1729008A Delocalization molecules and use thereof |
| 02/01/2006 | CN1728941A Generation of plants with altered oil content |
| 02/01/2006 | CN1728939A Generation of plants with altered oil content |
| 02/01/2006 | CN1727897A Method for preparing artificial antigen of 3-chlorine-1,2-propylene glycol |
| 02/01/2006 | CN1727488A Interfusion protein human serum protein and erythropoietin |
| 02/01/2006 | CN1727485A Highly expressed cotton ag2 gene possessing resistance on adversity induced by glyphosate |
| 02/01/2006 | CN1727483A Halotolerant, drought resistance gene from Thellugiella halophila, coded protein and application |